XML 108 R98.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Reporting - Revenue from Segments to Consolidated (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues [1] $ 352,585 $ 222,471 $ 969,581 $ 659,599
Adjusted EBITDA 28,055 13,765 74,049 42,018
Evolent Health Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 107,328 62,857 306,521 222,557
Clinical Solutions        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 245,257 159,614 663,060 437,042
Intersegment Eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 295 (458) (626) (1,356)
Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 352,585 222,471 969,581 659,599
Adjusted EBITDA 34,810 20,530 93,842 62,576
Operating Segments | Evolent Health Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 107,033 63,315 307,147 223,924
Adjusted EBITDA 18,507 (3,353) 41,854 9,120
Operating Segments | Clinical Solutions        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 245,257 159,614 663,060 437,031
Adjusted EBITDA 16,303 23,883 51,988 53,456
Corporate        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 0 0 0 0
Adjusted EBITDA $ (6,755) $ (6,765) $ (19,793) $ (20,558)
[1] See Note 18 for amounts attributable to unconsolidated related parties included in these line items.